Teva intends to market generic version of Victoza
Teva Pharmaceutical Industries Ltd., recently announced their intent to market a new drug in the U.S. Read More »
Acorda Therapeutics to present at upcoming conferences
Biotechnology company Acorda Therapeutics Inc., which is known for its work in neurological disorders, will present at two investor conferences this month. Read More »
Narcan available over the counter at Dallas, Houston Krogers
Kroger will sell Narcan nasal spray in its Dallas and Houston stores, without the need of a prescription. Read More »
Trump calls for reductions in pharmaceutical prices
President Trump recently met with pharmaceutical executives concerning the prices of drugs and the regulations surrounding them. Read More »
Taxpayer groups oppose changes to 'process by which drug prices are negotiated for Medicare Part D'
In a letter sent to the U.S. House of Representatives, leaders from Americans for Tax Reform, Citizens Against Government Waste, and the National Taxpayers Union, urged congressional members to "oppose any attempts to change the successful and cost-saving process by which drug prices are negotiated for Medicare Part D." Read More »
Walgreens, Rite Aid decrease sale price by $2 billion
Walgreens Boots Alliance and Rite Aid recently came to an agreement on a price reduction for the purchase of Rite Aid. Read More »
Digital Pharmacist forged from merger of two companies
Digital Pharmacist Inc. was launched Jan. 31 after the strategic merger of TeleManager Technologies Inc. and RxWiki Inc. Read More »
Xyzal Allergy approved for over-the-counter sales
Sanofi has received FDA approval of Xyzal Allergy 24HR, an over-the-counter option for those suffering with certain allergies. Read More »
UnitedAg to host annual meeting in March
Blue Shield of California and OptumRX will co-sponsor agricultural trade organization UnitedAg's 37th Annual Meeting and Conference in Napa, California, March 14-17. Read More »
MinuteClinic helps fill gap in women's health care
Access to affordable and dependable health care for women has become growing issue, and one facility says that it is prepared to play a big role in the solution in making women’s health care more accessible. Read More »
Former CMS head: PBMs driving down drug costs, 'price-fixing' won't work
As the Trump Administration and new Congress signal their intent to somehow deal with the issue of rising prescription drug prices, the notion of giving the federal government more power to negotiate drug prices in Medicare Part D has been suggested as one measure that might be implemented. Two leading experts this week, however, threw cold water on that proposal, noting that such negotiations already exist and serve to bring down drug costs. Read More »
FDA issues new naming guidance for biologics, biosimilars
The U.S. Food and Drug Administration released its final guidance on naming biologics and biosimilars. Read More »
Systech helps drug makers meet serialization deadline
Systech International's Serialized by November program helped numerous manufacturers comply with the standards outlined in the Drug Supply Chain Security Act before its deadline. Read More »
FDA gives new Alzheimer's treatment fast-track designation
ABBV-8E 12 -- a new Alzheimer’s treatment still in development -- received a fast-track designation from the U.S. Food and Drug Administration to be moved to clinical trials. Read More »
CTI BioPharma taps Metzger as its new CEO
CTI BioPharma Corp., a company that specializes in developing blood cancer treatments, has named Michael Metzger its new director. Read More »
FDA approves d-Methadone for clinical trials
Relmada Therapeutics, a biopharmaceutical company that specializes in developing treatments for central nervous system diseases, received approval from the U.S. Food and Drug Administration to advance a new therapy to clinical trials. Read More »
Linzess for constipation receives FDA approval
The U.S. Food and Drug Administration has approved Linzess, a treatment for people suffering with chronic idiopathic constipation. Read More »
Exparel pain reliever receives major endorsement
DePuy Synthes and Pacira Pharmaceuticals have entered into a partnership to promote pain reliever Exparel. Read More »
Narcan nasal application receives FDA approval
The U.S. Food and Drug Administration has given approval for the use of Narcan, an emergency treatment medication to counteract heroin overdoses, in a nasal spray form. Read More »
Diabetes-related kidney failure rate drops drastically among Native Americans
The rate of kidney failure related to diabetes among Native American adults dropped more than 50 percent between 1996 and 2013, the Centers for Disease Control and Prevention reported recently. Read More »
Alerts Sign-up